[1] Ait Ichou, M., Bachraoui, M., Hattaf, K., and Yousfi, N. Dynamics of a fractional opti-
mal control HBV infection model with capsids and CTL immune response, Math. Model.
Comput. 10(1) (2023) 239–244.
[2] Bachraoui, M., Hattaf, K., and Yousfi, N. Dynamics of a fractional order HBV infection
model with capsids and CTL immune response, Commun. Math. Biol. Neurosci., 2019 (2019),
Article ID 6.
[3] Boudjaj, L., Naji, A., and Ghafrani, F. Solving biharmonic equation as an optimal control
problem using localized radial basis functions collocation method, Eng. Anal. Bound. Elem.
107 (2019) 208–217.
[4] Churkin, A., Lewkiewicz, S., Reinharz, V., Dahari, H. and Barash, D. Efficient methods for
parameter estimation of ordinary and partial differential equation models of viral hepatitis
kinetics, Mathematics 8(9) (2020) 1483.
[5] Danane, J., Allali, K., and Hammouch, Z. Mathematical analysis of a fractional differential
model of HBV infection with antibody immune response, Chaos Solitons Fractals 136 (2020)
109787.
[6] Danane, J., Meskaf, A., and Allali, K. Optimal control of a delayed hepatitis B viral infection
model with HBV DNA-containing capsids and CTL immune response, Optim. Control Appl.
Methods 39(3) (2018) 1262–1272.
[7] di Filippo Villa, D., and Navas, M.-C. Vertical transmission of hepatitis B virus—An update.
Microorganisms 11(5) (2023) 1140.
[8] Elkaf, M., Meskaf, A., and Allali, K. Mathematical Modeling of HBV Infection with DNA-
Containing Capsids and Therapy, In Nonlinear Dynamics and Complexity: Mathematical
Modelling of Real-World Problems (pp. 413-427). Cham: Springer International Publishing,
2022.
[9] Foko, S. Dynamical analysis of a general delayed HBV infection model with capsids and
adaptive immune response in presence of exposed infected hepatocytes, J. Math. Biol. 88(6)
(2024) 75.
[10] Li, M., and Zu, J. The review of differential equation models of HBV infection dynamics, J.
Virol. Methods 266 (2019) 103–113.
[11] Manna, K. Global properties of an HBV infection model with HBV DNA-containing capsids
and CTL immune response, Int. J. Appl. Comput. Math. 3 (2017) 2323–2338.
[12] Manna, K., and Chakrabarty, S. P. Chronic hepatitis B infection and HBV DNA-containing
capsids: Modeling and analysis. Commnu Nonlinear Sci. Numer. Simul. 22(1–3) (2015)
383–395.
[13] Meskaf, A., and Allali, K. Optimal control of a delayed hepatitis B viral infection model with
DNA-containing capsids and cure rate, Trends in Biomathematics: Mathematical Modeling
for Health, Harvesting, and Population Dynamics: Selected works presented at the BIOMAT
Consortium Lectures, Morocco 2018 (2019): 23-33.
[14] Meskaf, A., Elkaf, M., and Aamoum, I. Dynamics of HBV infection model with DNA-
containing capsids, logistic hepatocyte growth and adaptive immune response, Commun.
Math. Biol. Neurosci. 2024 (2024), Article ID 58.
[15] Meskaf, A., Elkaf, M., and Allali, K. Viral infection dynamics of HBV DNA-containing
capsids with logistics growth and saturated rate, Commun. Math. Biol. Neurosci., 2023
(2023), Article ID 7.
[16] Soriano, V., Moreno-Torres, V., Treviño, A., de Jesús, F., Corral, O., and de Mendoza, C.
Prospects for controlling hepatitis B globally. Pathogens 13(4) (2024) 291.
[17] Sutradhar, R., and Dalal, D.C. Re-cycling of DNA-containing capsids enhances hepatitis B
virus infection, arXiv preprint (2023) arXiv:2309.15665.
[18] Sutradhar, R., and Dalal, D.C. Fractional-order models of hepatitis B virus infection with
recycling effects of capsids, Math. Methods Appl. Sci. 46(14) (2023) 15599–15625.
[19] World Health Organization. Global health sector strategy on viral hepatitis 2016–2021: To-
wards ending viral hepatitis, (2016).
[20] World Health Organization. Advocacy brief: Strategic approaches to eliminate hepatitis B
and C by 2030, (2016).